Dragonetti, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 483
EU - Europa 302
AS - Asia 158
SA - Sud America 4
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 952
Nazione #
US - Stati Uniti d'America 481
SE - Svezia 104
SG - Singapore 82
IT - Italia 53
IE - Irlanda 41
DE - Germania 35
CN - Cina 33
ID - Indonesia 27
FR - Francia 23
RU - Federazione Russa 15
FI - Finlandia 6
ES - Italia 5
IN - India 4
TR - Turchia 4
BE - Belgio 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
GB - Regno Unito 3
BR - Brasile 2
EU - Europa 2
HK - Hong Kong 2
IL - Israele 2
TW - Taiwan 2
UA - Ucraina 2
AU - Australia 1
BG - Bulgaria 1
CA - Canada 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
JP - Giappone 1
LT - Lituania 1
MX - Messico 1
MY - Malesia 1
NL - Olanda 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
Totale 952
Città #
Chandler 134
Ashburn 76
Singapore 66
Dublin 41
Chicago 28
Jakarta 27
Marseille 19
Milan 17
Beijing 16
New York 16
Bremen 14
Princeton 14
Boston 13
San Mateo 13
Washington 13
Munich 12
Moscow 10
Rome 7
Wilmington 7
Los Angeles 6
Ann Arbor 4
Falls Church 4
Brno 3
Brussels 3
Busto Arsizio 3
Cattolica 3
Dearborn 3
Helsinki 3
Lappeenranta 3
London 3
Nanjing 3
Paris 3
Santa Clara 3
Valladolid 3
Augusta 2
Bern 2
Como 2
Hong Kong 2
Madrid 2
Parma 2
Perugia 2
Pune 2
São Paulo 2
Abidjan 1
Alameda 1
Andover 1
Boardman 1
Cambridge 1
Cavalese 1
Clifton 1
Esslingen am Neckar 1
Fairfield 1
Falkenstein 1
Florence 1
Forest City 1
Frankfurt am Main 1
Groningen 1
Gunzenhausen 1
Hebei 1
Izmir 1
Jiaxing 1
Kaohsiung 1
Kuala Lumpur 1
Latiano 1
Leawood 1
Logan 1
Medellín 1
Meizhou 1
Mexico City 1
Moldova Noua 1
Montreal 1
Mumbai 1
Nanchang 1
Niš 1
Novokuznetsk 1
Nuremberg 1
Redmond 1
Redwood City 1
Seattle 1
Sofia 1
Taipei 1
Tivoli 1
Xi'an 1
Zurich 1
Totale 652
Nome #
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 86
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis 64
'Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study 63
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey 56
Developments in identifying and managing mucormycosis in hematologic cancer patients 52
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 51
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA 49
Rhodotorula infection in haematological patient: Risk factors and outcome 48
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) 48
Rhodotorula infection in haematological patient: Risk factors and outcome 46
Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study) 46
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey 44
Disseminated geosmithia argillacea infection in a patient with ph-positive acute lymphoblastic leukemia. Case report and literature review 41
Pharyngeal microbial signatures are predictive of the risk of fungal pneumonia in hematologic patients 37
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry 36
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA) 31
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey 25
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants 24
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax 21
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings 19
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report 16
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey 16
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry 16
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 15
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry 14
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey 12
SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report 10
Totale 986
Categoria #
all - tutte 6.685
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.685


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202015 0 0 0 0 0 0 4 6 2 3 0 0
2020/202117 0 0 3 4 1 0 4 0 0 0 5 0
2021/2022117 2 0 2 7 6 6 1 14 16 9 20 34
2022/2023384 45 43 24 61 32 44 27 31 44 9 18 6
2023/2024295 12 56 25 19 12 67 30 1 5 10 20 38
2024/2025141 15 8 37 37 44 0 0 0 0 0 0 0
Totale 986